Dallas, TX 11/3/2009 2:13:24 PM
News / Business

Most Active AMEX Stocks - APT, PLX, YMI

AMEX Stocks

Penny Stock Pick Report alerts investors on Top Stocks that would help investors to generate higher than average returns. Subscribe to FREE Stock Alerts by visiting: http://www.pennystockpickreport.com/
 

 

Alpha Pro Tech, Ltd. (AMEX:APT)  was one of the top gainers in today’s trading session and rallied 8.85% or $0.53 to close at $6.52 on an unusual massive volume of 1.56 million shares. The stock touched an intraday high and low of $6.778 and $6.20 respectively. So far in the last six months the stock has rallied over 297%. Alpha Pro Tech, Ltd. (Alpha Pro Tech) is in the business of protecting people, products and environments. The Company accomplishes this by developing, manufacturing and marketing a line of disposable protective apparel and infection control products for the cleanroom, industrial, pharmaceutical, medical and dental markets.


Protalix BioTherapeutics Inc. (AMEX:PLX)  was one of the top gainers in today’s trading session as it rallied over 10% and closed at $10.43 on huge volume of 1.49 million shares after Reuters reported that, according to TheMarker financial newspaper, Pfizer is considering a cooperation deal with Protalix BioTherapeutics Inc. and may even try to buy the Company. The stock price made a new 52 week high of $10.47.


YM BioSciences Inc. (USA) (AMEX:YMI) shares  jumped over 10% or $0.13 to end the day at $1.42 on 1.36 million shares after today it announced that an oral presentation at the American Society for Therapeutic Radiology and Oncology (ASTRO) 2009 Annual Meeting reported positive 48-month survival data for its EGFR-targeting antibody, nimotuzumab. The BEST trial was a randomized four-arm study treating patients with inoperable, locoregionally-advanced, stage III/IVa head and neck cancer with radiation alone, chemoradiation alone, or radiation or chemoradiation in combination with nimotuzumab. These data were a follow-up to 30-month survival data presented at ASCO 2009 and demonstrate that the benefit of adding nimotuzumab to radiation and chemoradiation is durable and persists for several years.

 


 ABOUT PennyStockPickReport.com
 
 Penny Stock Pick Report alerts investors on Top Stocks that would help investors to generate higher than average returns. These include various types of stocks with huge volume, penny stocks that are moving to the upside quickly, penny stocks with buy signals and companies with news. Our regular Stock Alerts, Penny Stock Trading Alerts helps investors to achieve incredible results in a short amount of time and our members have made remarkable profits of over 100%.